At Capsugel, we are devoted to developing capsules and other solutions to support our customers most difficult dosing challenges.
At Capsugel, we are driven by our focus on quality and have implemented numerous process quality initiatives to continuously improve the overall quality of our products.
At Capsugel, we are committed to ensuring an unmatched certainty of supply for our customers - and since you span the globe, so do we, with multiple production and business facilities worldwide.
World Class People
At Capsugel, we are focused on bringing and keeping top talent in our organization - it's our way of making sure you have the high-quality capsules you need, when and where you need them.
World Class People
At Capsugel, we are motivated by seeing our customers satisfied - so we keep your needs at the center of all our decisions to help make your job easier.
At Capsugel, we are dedicated to creating value for both our customers and their customers while always striving to provide investors with superior returns.
Capsugel’s Licaps® Capsules Maximize Delivery of Healthy Directions’ New Krill Omega Defense™ Supplement
Morristown, N.J., November 14, 2014 – Capsugel announced that its Licaps® liquid-filled hard capsule technology has been chosen by Healthy Directions to encapsulate its Krill Omega Defense™, a supplement rich in highly bioavailable omega-3 fatty acids. Healthy Directions is a direct-to-consumer nutritional supplement retailer and wholly-owned subsidiary of Helen of Troy Limited (NASDAQ: HELE).
Capsugel Expands Its Lipid Multiparticulate Technology Offering
Morristown, N.J., October 7, 2014 – Capsugel announced today the broad commercial availability of its proprietary lipid multiparticulate (LMP) technology. Capsugel’s LMP technology is an innovative drug-delivery platform with multiple applications – including bioavailability enhancement, taste-masking and modified release – for both pharmaceutical and health and nutrition (H&N) products. The company’s LMP technology is based on its melt-spray congeal (MSC) processing and combines the benefits of lipid-based formulations (LBF) with the functionality of a multiparticulate dosage form in one unique offering.
Hard to Swallow? Novel Solutions for pediatrics and patients who can't swallow pills
Nov. 20, 2014 2:00 PM ET, 11:00 AM PT - With both the FDA and EMA incentivizing increased emphasis on pediatric formulations through added patent exclusivity or mandatory inclusion of a pediatric investigation plan, developers are looking for novel ways to improve the patient experience. This webinar will review a new capsule and multiparticulate formulation approach that best meets key concerns for safety, patient compliance, and in-vivo performance across a variety of patient cohorts.
Inhalation Drugs in Capsule based Inhaler Systems: Optimizing DPI capsules on Formulation- Capsule-Device Interactions
Nov. 19, 2014 10 AM ET, 16:00 CET - Dry Powder Inhalation (DPI) is a leading drug delivery technology for the treatment of respiratory diseases, as well as increasingly for systemic drug delivery. Optimizing a DPI capsule is not an easy task; understanding the relationship between the device, formulation and capsule is key to improve drug performances.
This webinar provides insight into state-of-the-art technologies for inhalation drug development.
Clean Label Supplements : Claims and Market Opportunities
Nov. 20, 2014 16:00 CET - Did you know that over one-third of supplements launched in Western Europe last year featured a clean label claim such as ‘no allergens’ or ‘gluten free’? Please join Capsugel in partnership with Innova Marketing Insights to examine this important topic and help branded companies better understand and leverage this unique market opportunity.
Encap Drug Delivery
Based in Scotland, Encap’s focus on liquid and semi-solid encapsulation-based product development, and clinical and commercial manufacturing for the pharmaceutical industry, complements Capsugel’s recently-established Dosage Form Solutions (DFS) business unit which develops and manufactures innovative products for the healthcare industry.
Bend Research is now part of Capsugel's Dosage Form Solutions (DFS) business. Bend Research brings expertise in novel formulations, including spray-dried dispersions and hot-melt extrusion, as well as technologies in the areas of controlled-release, inhalation and bio-therapeutics. These capabilities complement Capsugel DFS’ premier capabilities in lipid and liquid formulations, modified and targeted release delivery and specialized manufacturing solutions.